| DB ID | MyCo_7085 |
| Title | Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit |
| Year | 2017 |
| PMID | 28161884 |
| Fungal Diseases involved | Invasive candidiasis |
| Associated Medical Condition | Critically ill septic patients |
| Genus | Candida |
| Species | spp. |
| Organism | Candida spp. |
| Ethical Statement | The study protocol was submitted and approved by our Local Ethics Committee (SepsiMed Study protocol number 0018329), and the study was performed in agreement with the principles set in the Declaration of Helsinki. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | PCT |
| Biomarker Full Name | Procalcitonin |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Italy |
| Cohort | This is a retrospective case–control study carried out in three internal medicine units (a total of 97 beds) of the University and General Hospital of Careggi, Florence, Italy, enrolling all cases of sepsis due to candidemia identified from January 1st 2012 to May 31st 2016. |
| Cohort No. | 64 Patients and 128 control |
| Age Group | 71.0 ± 14.8 |
| P Value | p<0.0001 |
| Sensitivity | 0.783 |
| Specificity | 0.72 |
| Positive Predictive Value | 0.151 |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | Vidas PCT Assay |
| ELISA kits | Vidas PCT kit (Brahms D-agnostics, Berlin, Germany) |
| Assay Data | None |
| Validation Techniques used | Vidas PCT Assay |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
